NCT04837703
MAP to Provide Access to Eltrombopag, for Treatment of Patients With Medically Significant Thrombocytopenia No drug interventions Not Available Not Available available NCT05255003
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis No drug interventions treatment 4 recruiting NCT05563064
Effect of Herbal Formulation on Thrombocytes Count No drug interventions treatment 3 recruiting NCT06565364
Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients No drug interventions Not Available Not Available completed NCT02389621
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures No drug interventions treatment 3 completed NCT00549484
Thrombopoietin Levels and Platelet Transfusion in Neonates No drug interventions Not Available Not Available completed NCT03968484
Platelet Transfusion in Sepsis Trial No drug interventions treatment Not Available withdrawn NCT02344979
The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC No drug interventions Not Available Not Available unknown_status NCT04917679
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP No drug interventions treatment 2 completed NCT03823079
Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia No drug interventions treatment 2 unknown_status NCT03326843
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure No drug interventions treatment 3 terminated NCT00336687
Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation. No drug interventions Not Available Not Available completed NCT00333333
Mechanism of Thrombocytopenia in Infants No drug interventions Not Available Not Available completed NCT02276651
Observational Trial of a Therapeutic Platelet Transfusion Regimen No drug interventions Not Available Not Available terminated NCT01000051
Eltrombopag for Post Transplant Thrombocytopenia treatment 2 completed NCT00471653
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy Not Available Not Available terminated NCT02862353
Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic No drug interventions Not Available Not Available completed NCT06455553
Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. No drug interventions screening Not Available recruiting NCT04437953
Avatrombopag for Thrombocytopenia in People With Cancer treatment 2 withdrawn NCT06087198
Clinical Performance Evaluation of T-TAS®01 HD Chip No drug interventions Not Available Not Available recruiting NCT03835598
Post-Operative Thrombocytopenia After Bio-prosthesis Implantation No drug interventions Not Available Not Available completed NCT03636698
Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway No drug interventions Not Available Not Available completed NCT03567798
Thrombocytopenia Induced by Chemotherapy No drug interventions treatment Not Available completed NCT05634005
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence No drug interventions health_services_research Not Available recruiting NCT02707497
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia treatment 2 / 3 recruiting NCT02948283
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia treatment 1 completed NCT00922883
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients treatment 2 completed NCT04906083
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia treatment 4 unknown_status NCT01676961
Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy supportive_care 2 terminated NCT02444728
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE treatment 3 terminated NCT00321711
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents supportive_care 2 completed NCT01368211
Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) No drug interventions basic_science 2 / 3 terminated NCT04631211
Thrombosomes® in Bleeding Thrombocytopenic Patients Study treatment 2 terminated NCT02267993
Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients treatment 4 completed NCT00907478
Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) treatment 4 completed NCT03391856
Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy treatment 2 / 3 terminated NCT05711485
Platelet-Directed Whole Blood Transfusion Strategy for Malaria No drug interventions supportive_care Not Available recruiting NCT06291415
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) treatment 1 recruiting NCT00004215
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia supportive_care 2 completed NCT00415532
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura treatment 3 completed NCT05983952
Anti-CD38 Antibody Treating APS With Thrombocytopenia No drug interventions treatment 2 recruiting NCT05087459
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma Not Available Not Available unknown_status NCT03554759
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure Not Available Not Available terminated NCT03815175
XIENCE 28 USA Study treatment Not Available completed NCT04155775
Effects of a Platelet Transfusion Best Practices Alert No drug interventions other Not Available completed NCT04272970
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) No drug interventions diagnostic Not Available completed NCT03355742
XIENCE 28 Global Study No drug interventions treatment Not Available completed NCT04348799
Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia No drug interventions Not Available Not Available completed NCT04070599
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. No drug interventions basic_science 3 completed NCT00110799
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C treatment 2 completed NCT01397149
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) treatment 1 / 2 terminated NCT00102336
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy treatment 3 completed NCT05382013
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment prevention 4 recruiting NCT05217719
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients treatment 4 unknown_status NCT03090919
The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis No drug interventions treatment Not Available withdrawn NCT00003619
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia treatment 1 / 2 completed NCT01162941
Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) No drug interventions treatment 2 unknown_status NCT03288441
Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT03701217
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML treatment 2 / 3 unknown_status NCT01444417
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients treatment 3 completed NCT03638817
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia treatment 2 completed NCT02032134
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia treatment 4 terminated NCT03754634
A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP treatment 2 completed NCT00261924
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days No drug interventions prevention 3 completed NCT02718716
Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia treatment 2 completed NCT01165996
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome treatment 1 / 2 completed NCT02244658
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia treatment 3 unknown_status NCT05585463
Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) No drug interventions Not Available Not Available completed NCT00283439
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma supportive_care 1 / 2 completed NCT05038722
Function of Platelets Used for Transfusions No drug interventions Not Available Not Available enrolling_by_invitation NCT06202625
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT treatment 2 / 3 not_yet_recruiting NCT02371330
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study No drug interventions Not Available Not Available completed NCT06433830
Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy supportive_care 2 recruiting NCT00735930
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 1 completed NCT06095648
Study Comparing Platelet Transfusion Volumes in Premature Babies No drug interventions treatment Not Available not_yet_recruiting NCT01805648
Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP treatment 3 unknown_status NCT02094248
rhTPO in Critical Patients With Thrombocytopenia No drug interventions treatment 2 / 3 unknown_status NCT00454857
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) No drug interventions Not Available Not Available completed NCT02263157
Evaluate the Association Between Infection and Thrombocytopenia No drug interventions Not Available Not Available completed NCT04889326
Collection of the Thrombo-VaxCov Cohort No drug interventions Not Available Not Available recruiting NCT01965626
A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP treatment 2 completed NCT06036966
The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients treatment 2 not_yet_recruiting NCT04014166
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia No drug interventions treatment Not Available active_not_recruiting NCT04673266
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma treatment 2 active_not_recruiting NCT00151866
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma No drug interventions treatment 3 completed NCT03617965
Mortality Due to Septic Shock Associated With Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT00418665
A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid supportive_care 2 completed NCT00508820
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP treatment 3 completed NCT04003220
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker No drug interventions Not Available Not Available recruiting NCT06187831
Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger No drug interventions Not Available Not Available recruiting NCT02241031
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia treatment 2 / 3 unknown_status NCT06521931
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients No drug interventions prevention 1 recruiting NCT04478227
TPO-Mimetic Use in Children for Hematopoietic Failure treatment 0 completed NCT05040776
COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients treatment 2 withdrawn NCT01356576
Effect of Hemodialysis Membranes on Platelet Count No drug interventions Not Available Not Available completed NCT04609891
Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors treatment Not Available completed NCT00073580
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) treatment 3 completed NCT00031980
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer supportive_care 2 completed NCT00260689
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia No drug interventions treatment 2 completed NCT01970189
The International ITP Registry No drug interventions Not Available Not Available unknown_status NCT02306044
Bleeding Prediction in Thrombocytopenia No drug interventions Not Available Not Available completed NCT05095844
National Vaccine Adverse Event Reporting Survey and Etiology No drug interventions Not Available Not Available unknown_status NCT01194167
Study of Eltrombopag in Platelet Refractory Thrombocytopenia No drug interventions treatment 2 withdrawn NCT01727401
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia No drug interventions prevention 4 terminated NCT01974401
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia No drug interventions prevention 2 completed NCT02805868
Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis No drug interventions treatment 0 withdrawn NCT06245746
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia No drug interventions treatment 1 not_yet_recruiting NCT00039910
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia No drug interventions prevention 3 completed NCT00771810
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer No drug interventions supportive_care 2 completed NCT01163110
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy No drug interventions treatment 1 completed NCT03716310
Platelet Reactivity in Septic Shock No drug interventions Not Available Not Available completed NCT00730314
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells No drug interventions treatment 1 / 2 completed NCT00420914
Strategies for Transfusion of Platelets (SToP) No drug interventions health_services_research 3 terminated NCT02780414
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers No drug interventions Not Available Not Available completed NCT01484314
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma No drug interventions treatment 2 terminated NCT03394755
Thrombosomes® in Bleeding Thrombocytopenic Patients No drug interventions treatment 1 completed NCT03303950
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis No drug interventions treatment 2 terminated NCT00102323
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy No drug interventions treatment 3 completed NCT02912208
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes No drug interventions treatment 2 active_not_recruiting NCT00305708
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission No drug interventions treatment 1 / 2 completed NCT00608738
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment No drug interventions health_services_research Not Available completed NCT01286038
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia No drug interventions treatment 1 terminated NCT06562738
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia No drug interventions treatment 4 recruiting NCT02679443
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy No drug interventions prevention Not Available completed NCT06491303
Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy No drug interventions Not Available Not Available not_yet_recruiting NCT03767803
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women No drug interventions Not Available Not Available unknown_status NCT00472290
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) No drug interventions treatment Not Available completed NCT00118664
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children No drug interventions Not Available Not Available completed NCT00961064
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 completed NCT06053021
Antiplatelet Therapy for AIS Patients With Thrombocytopenia No drug interventions prevention Not Available recruiting NCT01196884
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment No drug interventions Not Available Not Available unknown_status NCT02078284
Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets No drug interventions treatment 1 completed NCT04543279
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia No drug interventions treatment 2 terminated NCT00004787
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes No drug interventions treatment 2 completed NCT00678587
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures No drug interventions treatment 3 terminated NCT02298933
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia No drug interventions treatment 2 completed NCT00001533
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine No drug interventions treatment 1 completed NCT00239733
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection No drug interventions treatment 4 terminated NCT03838354
A Clinical Trial of the Low Dose Chidamide in the Management of Refractory ITP No drug interventions treatment 2 unknown_status NCT06349577
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury No drug interventions prevention Not Available not_yet_recruiting NCT01660347
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant No drug interventions supportive_care Not Available withdrawn NCT03515447
Romiplostim in Thoracic Transplantation No drug interventions Not Available Not Available completed NCT00501345
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia No drug interventions treatment 3 terminated NCT00413283
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) No drug interventions supportive_care 2 completed NCT04896528
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia No drug interventions treatment 2 unknown_status NCT05958511
Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03605511
TTP and aHUS in Complicated Pregnancies No drug interventions Not Available Not Available unknown_status NCT05225493
HIV Indicator Diseases in Hospital and Primary Care No drug interventions Not Available Not Available unknown_status NCT02323178
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia No drug interventions treatment 1 / 2 completed NCT02906878
Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter No drug interventions Not Available Not Available unknown_status NCT00004378
Stem Cell Transplantation (SCT) for Genetic Diseases No drug interventions treatment Not Available completed NCT00748878
Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) No drug interventions Not Available Not Available completed NCT00116688
Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) No drug interventions treatment 3 completed NCT05944809
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients No drug interventions prevention 2 recruiting NCT00263809
Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products No drug interventions treatment 0 completed NCT02845609
Efficacy of Sialic Acid GNE Related Thrombocytopenia No drug interventions treatment 2 completed NCT05199909
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia No drug interventions treatment 2 recruiting NCT03806556
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia No drug interventions prevention 1 / 2 terminated NCT00594685
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) No drug interventions Not Available Not Available terminated NCT02530515
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT05053100
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study No drug interventions Not Available Not Available recruiting NCT03998059
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients No drug interventions Not Available Not Available unknown_status NCT05998759
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia No drug interventions treatment 2 not_yet_recruiting NCT05410249
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP No drug interventions Not Available Not Available recruiting NCT04931849
Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G) No drug interventions treatment 0 recruiting NCT02074436
PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) No drug interventions treatment 2 terminated NCT00128713
Optimal Platelet Dose Strategy for Management of Thrombocytopenia No drug interventions treatment 3 completed NCT02783313
Pathogen Reduction Evaluation & Predictive Analytical Rating Score No drug interventions treatment Not Available completed NCT03712618
The SOLID Platelet Study No drug interventions treatment 2 recruiting NCT03633019
High-dose Use of rhTPO in CIT Patients No drug interventions treatment 4 unknown_status NCT01153919
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia No drug interventions treatment 2 terminated NCT00787241
Platelet Count Trends in Pre-eclamptic Parturients No drug interventions Not Available Not Available completed NCT05360134
Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation No drug interventions treatment Not Available unknown_status NCT03515096
Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT No drug interventions treatment 3 completed NCT04800458
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis No drug interventions diagnostic Not Available recruiting NCT00039858
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin No drug interventions treatment 4 completed NCT01428635
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy No drug interventions supportive_care 2 / 3 completed NCT02487563
Prospective Study of Patients With Thrombocytopenia Following HSCT No drug interventions treatment 3 completed NCT00909363
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients No drug interventions treatment 2 terminated NCT00015639
Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus No drug interventions Not Available Not Available completed NCT00049725
Daclizumab to Treat Chronic Immune Thrombocytopenia No drug interventions treatment 2 completed NCT01821625
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C No drug interventions treatment 2 / 3 terminated NCT03059030
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia No drug interventions treatment Not Available active_not_recruiting NCT00001630
Treatment of Autoimmune Thrombocytopenia (AITP) No drug interventions treatment 1 completed NCT05396157
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study No drug interventions Not Available Not Available active_not_recruiting NCT00074165
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen No drug interventions treatment 2 terminated NCT05439265
EMR Tool Impact on HIT Documentation and Management No drug interventions Not Available Not Available completed NCT00002665
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia No drug interventions treatment 2 completed NCT05411874
A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP No drug interventions treatment 2 not_yet_recruiting NCT05672420
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT01481220
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 completed NCT04797182
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma No drug interventions prevention 2 unknown_status NCT05353673
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia No drug interventions treatment 2 unknown_status NCT00012376
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer No drug interventions treatment 1 completed NCT02039076
A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects No drug interventions treatment 1 completed NCT02227576
Prevention of Thrombocytopenia in Glioblastoma Patients No drug interventions treatment 2 terminated NCT03429660
French Adult Primary Immune Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT00037791
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia No drug interventions prevention 3 completed NCT01987791
Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis No drug interventions Not Available Not Available unknown_status NCT03688191
Study of Sirolimus in CTD-TP in China No drug interventions treatment 4 unknown_status NCT00759980
Transfusing Neonates Based on Platelet Mass No drug interventions Not Available Not Available completed NCT00903929
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation No drug interventions treatment 1 completed NCT01355289
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 No drug interventions treatment 2 completed NCT00948792
Study of the Effect of Differing Platelet Transfusion Times in Neonates No drug interventions treatment Not Available completed NCT06001567
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC No drug interventions treatment 2 recruiting NCT02578901
American Trial Using Tranexamic Acid in Thrombocytopenia No drug interventions prevention 3 completed NCT05193201
A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease No drug interventions treatment 1 unknown_status NCT01791101
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. No drug interventions treatment 2 completed NCT00303472
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) No drug interventions treatment 2 completed NCT03195010
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia No drug interventions supportive_care 2 terminated NCT01013181
Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults No drug interventions Not Available Not Available completed NCT02068755
Blood Products in Cardiac Surgery No drug interventions Not Available Not Available completed NCT01002755
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT02858323
Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion No drug interventions Not Available Not Available completed NCT00614523
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) No drug interventions supportive_care 2 completed NCT01147809
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag supportive_care 2 completed NCT00102726
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy treatment 2 completed NCT01440374
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia supportive_care 2 completed NCT01236014
Indirect Comparison Between Eltrombopag & Romiplostim No drug interventions Not Available Not Available completed NCT01235988
Meta-analysis - Eltrombopag No drug interventions Not Available Not Available completed NCT01657552
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects No drug interventions other 1 completed NCT01055600
Milk-only Lactation Study for Patients on Eltrombopag No drug interventions Not Available 4 withdrawn NCT02158936
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) No drug interventions treatment 3 terminated NCT01957176
A Rollover Study to Provide Continued Treatment With Eltrombopag No drug interventions treatment 4 completed NCT00358540
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide No drug interventions supportive_care 1 completed